real-time PCR
At the AMP annual meeting this week, the company outlined its technology and vision for a speedy, low-cost, high-accuracy diagnostic.
Alercell to Distribute Amoy Diagnostic Ros1 Gene Fusion Detection Kit in US
The 14-fusion PCR assay for lung cancer subtyping is available for research-use only but will be more broadly distributed when the kits gain FDA clearance.
Qiagen Gets CE Mark for High-Capacity Syndromic Testing Platform
The company also launched updated versions of its CE-marked respiratory and gastrointestinal testing panels for use on the QiaStat-Dx systems.
Genetic Signatures Wins Contract From Public Health Wales for Enteric Pathogen Testing
Under the three-year contract, worth up to A$1.8 million (US$1.4 million) per year, the Australian firm will provide testing to seven sites within Wales.
COVID-19 accelerated the growth of several product portfolios, but under CEO Thierry Bernard, the company is ready to put the pandemic behind it — mostly.